BioXcel Therapeutics to Participate in Canaccord Genuity 45th Annual Growth Conference
BioXcel Therapeutics to Participate in Canaccord Genuity 45th Annual Growth Conference GlobeNewswire August 11, 2025 NEW HAVEN, Conn., Aug. 11, 2025 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced that Vimal Mehta, Ph.D., CEO of BioXcel Therapeutics, will participate in a […]